The report "Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2030", is projected to reach USD 4.75 billion in 2030 from USD 3.13 billion in 2025 at a CAGR of 8.68% between 2025 and 2030.
Browse 293 market data Tables and 50 Figures spread through 293 Pages and in-depth TOC on "Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/live-cell-imaging-market-163914483.html
Growth in the live cell imaging market is supported by the ongoing advancements in imaging technologies for various cellular imaging applications, as well as an increase in government funding and grants for enhancing life science research and drug development. Moreover, as the number of chronic diseases rises globally, pharmaceutical and biotechnology companies are increasingly adopting high-content screening and imaging technologies to improve drug research and development. Additionally, live cell imaging techniques are being increasingly utilized for the development of personalized medicines, opening new growth opportunities for players in this market. However, the high cost of purchase and maintenance of cellular imaging equipment presents a significant challenge to the widespread adoption of these products by small pharmaceutical companies and academic institutes with limited budgets.
The products segment accounted for the largest share of the live cell imaging market, by offering, in 2024.
Based on offerings, the live cell imaging market is divided into products, software, and services. The product segment is further subdivided into instruments and consumables. In 2024, the product segment held the largest share of the live cell imaging market by offering. The large share of the product segment can be attributed to increasing demand for imaging systems such as microscopes, cameras, and cell analyzers along with the need for consistent use of consumables like reagents, dyes, and culture media. As research in cell biology, cancer, and drug discovery increases, laboratories and research institutions require reliable, high-performance equipment and a regular supply of consumables to support continuous experimentation and the growth of the live cell imaging products market.
The high-content screening technology is expected to register the highest CAGR within the live cell imaging market by technology during the forecast period.
Based on technology, the live cell imaging market is segmented into time-lapse microscopy, fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), high-content screening, and other technologies. The high-content screening technology registered the highest CAGR in the live cell imaging technology market during the forecast period. This growth can be attributed to the ability of HCS techniques to combine automated imaging with quantitative data analysis, which is essential for drug discovery and functional genomic analysis.
Asia Pacific is expected to be the fastest-growing region of the live cell imaging market during the forecast period.
The Live cell imaging market is divided into six regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2024, Aisa Pacific registered the highest CAGR within the live cell imaging market during the forecast period. This growth is supported by the increasing investments in healthcare infrastructure, rising government support for life science research, and expanding biotechnology and pharmaceutical industries that are pushing the demand for advanced imaging technologies. India, China, and Japan are investing significantly in life science research, particularly in areas such as cancer biology, stem cell research, and drug development, and key players in the live cell imaging market are expanding their product presence in these emerging economies further supporting the growth of the Asia Pacific live cell imaging market.
Key players in the live cell imaging market include Danaher (US), Zeiss Group (Germany), Nikon Corporation (Japan), Evident (Japan), Revvity (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Nanoentek (Korea), Bruker (US), BD (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Tecan Trading AG (Switzerland), and Corning Incorporated (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/